🚀 VC round data is live in beta, check it out!
InMode Valuation Multiples
Discover revenue and EBITDA valuation multiples for InMode and similar public comparables like Barco, ChemoMetec, Integra Lifesciences, SS Innovations and more.
InMode Overview
About InMode
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Founded
2008
HQ
Employees
660
Website
Financials (LTM)
EV
$381M
InMode Financials
InMode reported last 12-month revenue of $370M and EBITDA of $94M.
In the same LTM period, InMode generated $289M in gross profit, $94M in EBITDA, and $91M in net income.
Revenue (LTM)
InMode P&L
In the most recent fiscal year, InMode reported revenue of $370M and EBITDA of $97M.
InMode expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $370M | XXX | $370M | XXX | XXX | XXX |
| Gross Profit | $289M | XXX | $291M | XXX | XXX | XXX |
| Gross Margin | 78% | XXX | 79% | XXX | XXX | XXX |
| EBITDA | $94M | XXX | $97M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 26% | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 26% | XXX | XXX | XXX |
| Net Profit | $91M | XXX | $94M | XXX | XXX | XXX |
| Net Margin | 24% | XXX | 25% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
InMode Stock Performance
InMode has current market cap of $928M, and enterprise value of $381M.
Market Cap Evolution
InMode's stock price is $14.65.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $381M | $928M | 2.2% | XXX | XXX | XXX | $1.48 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInMode Valuation Multiples
InMode trades at 1.0x EV/Revenue multiple, and 4.0x EV/EBITDA.
EV / Revenue (LTM)
InMode Financial Valuation Multiples
As of April 18, 2026, InMode has market cap of $928M and EV of $381M.
Equity research analysts estimate InMode's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
InMode has a P/E ratio of 10.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $928M | XXX | $928M | XXX | XXX | XXX |
| EV (current) | $381M | XXX | $381M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 4.0x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBIT | 4.1x | XXX | 3.9x | XXX | XXX | XXX |
| EV/Gross Profit | 1.3x | XXX | 1.3x | XXX | XXX | XXX |
| P/E | 10.2x | XXX | 9.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 4.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified InMode Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
InMode Margins & Growth Rates
InMode's revenue in the last 12 month grew by 1%.
InMode's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.
InMode's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
InMode's rule of X is 23% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
InMode Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | (0%) | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | (6%) | XXX | (10%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 48% | XXX | 49% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 55% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
InMode Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| InMode | XXX | XXX | XXX | XXX | XXX | XXX |
| Barco | XXX | XXX | XXX | XXX | XXX | XXX |
| ChemoMetec | XXX | XXX | XXX | XXX | XXX | XXX |
| Integra Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| SS Innovations | XXX | XXX | XXX | XXX | XXX | XXX |
| QuidelOrtho | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
InMode M&A Activity
InMode acquired XXX companies to date.
Last acquisition by InMode was on XXXXXXXX, XXXXX. InMode acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by InMode
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialInMode Investment Activity
InMode invested in XXX companies to date.
InMode made its latest investment on XXXXXXXX, XXXXX. InMode invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by InMode
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout InMode
| When was InMode founded? | InMode was founded in 2008. |
| Where is InMode headquartered? | InMode is headquartered in United States. |
| How many employees does InMode have? | As of today, InMode has over 660 employees. |
| Who is the CEO of InMode? | InMode's CEO is Moshe Mizrahy. |
| Is InMode publicly listed? | Yes, InMode is a public company listed on Nasdaq. |
| What is the stock symbol of InMode? | InMode trades under INMD ticker. |
| When did InMode go public? | InMode went public in 2019. |
| Who are competitors of InMode? | InMode main competitors are Barco, ChemoMetec, Integra Lifesciences, SS Innovations. |
| What is the current market cap of InMode? | InMode's current market cap is $928M. |
| What is the current revenue of InMode? | InMode's last 12 months revenue is $370M. |
| What is the current revenue growth of InMode? | InMode revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of InMode? | Current revenue multiple of InMode is 1.0x. |
| Is InMode profitable? | Yes, InMode is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of InMode? | InMode's last 12 months EBITDA is $94M. |
| What is InMode's EBITDA margin? | InMode's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of InMode? | Current EBITDA multiple of InMode is 4.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.